Isomorphic Labs closes $5bn Series C
What happened
On 17 November 2026, Isomorphic Labs, the AI drug discovery company spun out of Google DeepMind, announced it had closed a $5bn Series C round co-led by Greenoaks and Sequoia Capital, with new investors including Andreessen Horowitz and full participation from existing backers such as Alphabet's GV and Capital G. The company said the funds will be used to advance drug candidates into clinical trials. The report noted this is the company's second large round within six months, having raised $2.1bn in May 2026.
Written by AI from the reports · updated 1 d ago
Timeline
Follow the reports to see the event from each side.
- The DecoderIsomorphic Labs raises $5 billion in its second mega-round within six months
Isomorphic Labs has raised $5 billion, just six months after a $2.1 billion round. Alphabet's AI drug discovery company, led by Demis Hassabis, plans to use the funding to push its drug pipeline toward clinical trials. The company has no approved drugs yet.
- TechCrunch · AIIsomorphic Labs raises $5B as it looks to take drug candidates to clinical trials
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google’s DeepMind in 2021, has raised $5 billion in a Series C funding round.
Heat of this event
Current heat 8·Peak in the comparable range 19(Nov 18 00:00)·Change over 24 hours in the comparable range -50%
The trend compares only the same accounts observed without a break, so its range can be narrower than the current heat count. Move the pointer or tap the chart to see each hour; with a keyboard, use the left and right arrow keys.